Skip to main content

RETRACTION article

Front. Immunol.
Sec. Inflammation
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1521254
This article is part of the Research Topic Community Series in Translational Insights into Mechanisms and Therapy of Organ Dysfunction in Sepsis and Trauma, volume III View all 20 articles

Retraction: Baricitinib protects mice from sepsis-induced cardiac dysfunction and multiple-organ failure

Provisionally accepted
Frontiers Editorial Office Frontiers Editorial Office *
  • Frontiers Media SA, Lausanne, Switzerland

This article is a retraction of:

  1. Baricitinib protects mice from sepsis-induced cardiac dysfunction and multiple-organ failure

    1. Read original article

The final, formatted version of the article will be published soon.

    “Retraction: Baricitinib protects mice from sepsis-induced cardiac dysfunction and multiple-organ failure” Verra C., Mohammad S, Ferreira Alves G, Porchietto E, Coldewey S.M., Collino M., Thiemermann C. (2023). Baricitinib protects mice from sepsis-induced cardiac dysfunction and multiple-organ failure. Frontiers in Immunology 14:1223014. doi: 10.3389/fimmu.2023.1223014. Following publication, concerns were raised regarding the integrity of the images in the published figure 4. Western Blot images in Figure 4A showed duplication of bands (Total JAK2 female group). The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted. This retraction was approved by the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction. Sina Maren Coldewey does not agree to this retraction. The other authors did not respond to correspondence regarding this retraction.

    Keywords: Sepsis, Baricitinib, janus kinase, Cardiac dysfunction, Multiple-organ failure

    Received: 01 Nov 2024; Accepted: 01 Nov 2024.

    Copyright: © 2024 Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Frontiers Editorial Office, Frontiers Media SA, Lausanne, Switzerland

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.